Brain training app shows promise for mild cognitive impairment
NCT ID NCT06264557
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a cognitive training software called SUPERBRAIN DEX in 140 people aged 50–85 with mild cognitive impairment (MCI), a condition that can lead to dementia. Participants used the software for 15–30 minutes daily, while a control group received an educational booklet on dementia prevention. The goal was to see if the software could improve memory and thinking better than simple education. The trial is now complete, and results will show whether this digital approach can help slow cognitive decline.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SUPERBRAIN DEX cognitive training software
What this could lead to
If it works, this software could offer a safe, drug-free way to help people with mild cognitive impairment maintain or improve their memory and thinking skills.
What could go wrong
This is a small, completed trial with 140 participants. The results may not apply to everyone, and the improvement might be modest. There is no guarantee the software will outperform simple education.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Hospital
Suwon, South Korea
-
Chonnam National University Hospital
Kwangju, South Korea
-
Ewha Womans University Seoul Hospital
Seoul, South Korea
-
Gachon University Gil Medical Center
Incheon, South Korea
-
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, 11923, South Korea
-
Hanyang University Seoul Hospital
Seoul, South Korea
-
Inha University Hospital
Incheon, 22332, South Korea
-
Inje University Haeundae Paik Hospital
Busan, South Korea
-
Koera University Guro Hospital
Seoul, South Korea
-
Korea University Anam Hospital
Seoul, South Korea
-
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
-
The Catholic University of Korea, St. Vincent's Hospital
Suwon, South Korea